Efficacy and safety of ticagrelor versus prasugrel in smokers and nonsmokers with acute coronary syndromes

The efficacy and safety of ticagrelor versus prasugrel according to smoking status in patients with acute coronary syndromes (ACS) are not known. We assessed the efficacy and safety of ticagrelor versus prasugrel according to smoking status in patients with ACS undergoing invasive management.

Source: International Journal of Cardiology - June 11, 2021 Category: Cardiology Authors: Shqipdona Lahu, Gjin Ndrepepa, Senta Gewalt, Stefanie Sch üpke, Costanza Pellegrini, Isabell Bernlochner, Alp Aytekin, Franz-Josef Neumann, Maurizio Menichelli, Gert Richardt, Salvatore Cassese, Erion Xhepa, Sebastian Kufner, Hendrik B. Sager, Michael Jo Source Type: research